TY - JOUR
T1 - Transrectal ultrasound for prostate cancer
T2 - Perspectives from National Cheng Kung University Hospital
AU - Tsai, Yuh Shyan
AU - Chen, Chia Horng
AU - Lin, Yi Hsiang
AU - Tzai, Tzong Shin
N1 - Funding Information:
The authors wish to thank Professor Cheng-Keng Chuang for inviting us to submit this paper. This review was partly supported by a collaboration between National Cheng Kung University Hospital, Douliou Branch, and the National Yunlin University of Science and Technology.
PY - 2007
Y1 - 2007
N2 - Following a recent in the increase in the incidence and cancer deaths of prostate cancer, transrectal ultrasound (TRUS) has become an important tool that enables accurate sampling of prostate tissue for histologic examination in patients with a high risk of harboring cancer (patients with elevated prostate-specific antigen and abnormal digital rectal examination). The biopsy protocol continues to evolve with progress in ultrasound technology. In countries with a rising incidence of prostate cancer, it is important to determine an optimal biopsy strategy. In this article, we briefly summarize our experience and the problems we encountered when using TRUS in diagnosing prostate cancer at National Cheng Kung University Hospital. We also review progress in biopsy protocols according to the targeted lesion or systematic random biopsy protocols. We consider promising predictive models regarding the optimal number of biopsy cores and the probability of being diagnosed with prostate cancer. This information will enable biopsy strategies to be better applied according to the requirements of individual institutions.
AB - Following a recent in the increase in the incidence and cancer deaths of prostate cancer, transrectal ultrasound (TRUS) has become an important tool that enables accurate sampling of prostate tissue for histologic examination in patients with a high risk of harboring cancer (patients with elevated prostate-specific antigen and abnormal digital rectal examination). The biopsy protocol continues to evolve with progress in ultrasound technology. In countries with a rising incidence of prostate cancer, it is important to determine an optimal biopsy strategy. In this article, we briefly summarize our experience and the problems we encountered when using TRUS in diagnosing prostate cancer at National Cheng Kung University Hospital. We also review progress in biopsy protocols according to the targeted lesion or systematic random biopsy protocols. We consider promising predictive models regarding the optimal number of biopsy cores and the probability of being diagnosed with prostate cancer. This information will enable biopsy strategies to be better applied according to the requirements of individual institutions.
UR - http://www.scopus.com/inward/record.url?scp=35348869939&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35348869939&partnerID=8YFLogxK
U2 - 10.1016/S0929-6441(08)60035-1
DO - 10.1016/S0929-6441(08)60035-1
M3 - Review article
AN - SCOPUS:35348869939
SN - 0929-6441
VL - 15
SP - 183
EP - 190
JO - Journal of Medical Ultrasound
JF - Journal of Medical Ultrasound
IS - 3
ER -